199 related articles for article (PubMed ID: 36244989)
1. Efficacy of a formulation of sarolaner/moxidectin/pyrantel (Simparica Trio
Bezerra-Santos MA; Mendoza-Roldan JA; Sgroi G; Lia RP; Venegoni G; Solari Basano F; Nele R; Mahabir SP; Borowski S; Geurden T; Otranto D
Parasit Vectors; 2022 Oct; 15(1):370. PubMed ID: 36244989
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
Otranto D; Colella V; Crescenzo G; Solari Basano F; Nazzari R; Capelli G; Petry G; Schaper R; Pollmeier M; Mallia E; Dantas-Torres F; Lia RP
Vet Parasitol; 2016 Aug; 227():118-21. PubMed ID: 27523947
[TBL] [Abstract][Full Text] [Related]
3. Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio
Becskei C; Willesen JL; Schnyder M; Wozniakiewicz M; Miroshnikova N; Mahabir SP
Parasit Vectors; 2020 Jul; 13(1):385. PubMed ID: 32727548
[TBL] [Abstract][Full Text] [Related]
4. Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe and the USA.
Becskei C; Kryda K; Fias D; Follis SL; Wozniakiewicz M; Mahabir SP; Farkas R
Parasit Vectors; 2020 Mar; 13(1):70. PubMed ID: 32113470
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of five common tick species infesting dogs in the USA.
Kryda K; Mahabir SP; Chapin S; Holzmer SJ; Bowersock L; Everett WR; Riner J; Carter L; Young D
Parasit Vectors; 2020 Mar; 13(1):77. PubMed ID: 32113476
[TBL] [Abstract][Full Text] [Related]
6. Prevention of canine ocular thelaziosis (Thelazia callipaeda) with a combination of milbemycin oxime and afoxolaner (Nexgard Spectra
Lebon W; Guillot J; Álvarez MJ; Antonio Bazaga J; Cortes-Dubly ML; Dumont P; Eberhardt M; Gómez H; Pennant O; Siméon N; Beugnet F; Halos L
Parasite; 2019; 26():1. PubMed ID: 30644355
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the prophylactic activity of a slow-release insecticide collar and a moxidectin spot-on formulation against Thelazia callipaeda infection in naturally exposed dogs in France.
Lechat C; Siméon N; Pennant O; Desquilbet L; Chahory S; Le Sueur C; Guillot J
Parasit Vectors; 2015 Feb; 8():93. PubMed ID: 25884443
[TBL] [Abstract][Full Text] [Related]
8. Laboratory studies evaluating the efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) for the treatment and control of flea infestations on dogs.
Kryda K; Mahabir SP; Carter L; Everett WR; Young DR; Meyer L; Thys M; Chapin S; Holzmer SJ; Becskei C
Parasit Vectors; 2020 Mar; 13(1):57. PubMed ID: 32113466
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe.
Becskei C; Fias D; Mahabir SP; Farkas R
Parasit Vectors; 2020 Mar; 13(1):72. PubMed ID: 32113486
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a novel chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against four common tick species infesting dogs in Europe.
Becskei C; Liebenberg J; Thys M; Mahabir SP
Parasit Vectors; 2020 Mar; 13(1):100. PubMed ID: 32113468
[TBL] [Abstract][Full Text] [Related]
11. Safety of Simparica Trio
Mathur S; Malpas PB; Mahabir S; Boucher J; Pullins A; Gagnon G; McTier TL; Maeder S
Parasit Vectors; 2023 Mar; 16(1):119. PubMed ID: 37004097
[TBL] [Abstract][Full Text] [Related]
12. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%.
Bianciardi P; Otranto D
Vet Parasitol; 2005 Apr; 129(1-2):89-93. PubMed ID: 15817208
[TBL] [Abstract][Full Text] [Related]
13. Preventive efficacy of six monthly oral doses of Simparica Trio
Myers JAE; Holzmer S; McCall JW; Mahabir SP; McTier TL; Maeder SJ; Kryda K
Parasit Vectors; 2022 Mar; 15(1):81. PubMed ID: 35277191
[TBL] [Abstract][Full Text] [Related]
14. Update on the treatment and prevention of ocular thelaziosis (Thelazia callipaeda) in naturally infected dogs from Spain.
Marino V; Gálvez R; Mascuñán C; Domínguez I; Sarquis J; Montoya A; Barrera JP; Zenker C; Checa R; Hernández M; Miró G
Int J Parasitol; 2021 Jan; 51(1):73-81. PubMed ID: 33091413
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats.
Otranto D; Solari Basano F; Pombi M; Capelli G; Nazzari R; Falsone L; Petry G; Pollmeier MG; Lia RP
Parasit Vectors; 2019 Jan; 12(1):25. PubMed ID: 30635002
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Simparica Trio™, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs.
Becskei C; Thys M; Kryda K; Meyer L; Martorell S; Geurden T; Dreesen L; Fernandes T; Mahabir SP
Parasit Vectors; 2020 Mar; 13(1):99. PubMed ID: 32113471
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the speed of kill of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against induced infestations of Ixodes scapularis on dogs.
Holzmer S; Kryda K; Mahabir SP; Everett W
Parasit Vectors; 2020 Mar; 13(1):76. PubMed ID: 32113473
[TBL] [Abstract][Full Text] [Related]
18. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs.
Kryda K; Six RH; Walsh KF; Holzmer SJ; Chapin S; Mahabir SP; Myers M; Inskeep T; Rugg J; Cundiff B; Pullins A; Ulrich M; McCall JW; McTier TL; Maeder SJ
Parasit Vectors; 2019 Sep; 12(1):445. PubMed ID: 31506094
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio™) for the prevention of experimental Angiostrongylus vasorum infection in dogs.
Becskei C; Thys M; Doherty P; Mahabir SP
Parasit Vectors; 2020 Mar; 13(1):64. PubMed ID: 32113483
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of combination products containing sarolaner, moxidectin and pyrantel (Simparica Trio™) or afoxolaner and milbemycin (NexGard Spectra
Packianathan R; Hodge A; Bruellke N; Jackson C; Maeder S
Parasit Vectors; 2020 Sep; 13(1):448. PubMed ID: 32891172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
